Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Biphasic Insulin Aspart 30 FlexPen in insulin-naive adults with Type 2 d…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers [Phase 4]
Phase 4 trial evaluating sitagliptin (Januvia) for healing chronic diabetic foot ulcers in type 2 diabetes was terminated; results were post…
-
CLINICAL_TRIALS research · 2017-01-06Clinical Trial Update: Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes
Observational study evaluating Biphasic Insulin Aspart 30 used alone or with oral hypoglycemic agents in adults with Type 2 diabetes; the st…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes [Phase 2]
This Phase 2 trial update reports glycemic control outcomes for biphasic insulin aspart 70/30 in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing three biphasic insulin aspart formulations (70/30, 50/50, and 30/70) in adults with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30 and 50 in adults with Type 2 diabetes; the …
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of adding teneligliptin to insulin therapy in patients with Type 2 Diabetes Mellitus, with…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy. [EARLY_Phase 1]
An early Phase 1, multi-center clinical study is evaluating a traditional Chinese medicine intervention for diabetic distal symmetric polyne…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Biphasic Insulin Aspart 30 in adults with Type 1 or Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients [Phase 3]
A Phase 3 trial assessing the efficacy and safety of lixisenatide versus insulin glulisine as add-on to insulin glargine, with or without me…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial update assessing the pharmacokinetics, pharmacodynamics, and safety of biphasic insulin aspart 30 in people with ty…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing two biphasic insulin aspart regimens in adults with Type 2 diabetes to assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes [Phase 3]
A Phase 3 trial compared Biphasic Human Insulin 30 with Biphasic Insulin Aspart in subjects with diabetes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly [Phase 1]
This clinical trial update reports a Phase 1 study comparing daily versus weekly subcutaneous semaglutide dosing; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects
An observational study evaluating the safety and effectiveness of intravenous NovoRapid in hospitalized subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial of NovoLog (insulin aspart) in subjects with Type 1 and Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: Study of EndoBarrier Liner for Treatment of Type 2 Diabetes Study [NA]
A completed clinical trial evaluating the EndoBarrier Liner for treatment of type 2 diabetes; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients [Phase 1]
A Phase 1 randomized, placebo-controlled, multiple-dose escalation study assessing safety, pharmacokinetics, and pharmacodynamics of SHR0534…
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy [Phase 4]
Phase 4 trial evaluating whether adding pentoxifylline to losartan reduces NT-proBNP levels more effectively than increasing the losartan do…
-
FDA approval · 2016-12-29FDA Approved: GLIPIZIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma Holdings, Inc.'s original application for a generic version of glipizide to treat type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Study for Pre-Surgical Weight Loss in Type II Diabetes Patients [Phase 2]
Phase 2 trial update from Morphic Medical Inc. on pre-surgical weight loss in patients with type 2 diabetes mellitus and obesity; the study …
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: A Study of the GI Sleeve for the Treatment of Type 2 Diabetes [Phase 1, Phase 2]
A Phase 1/2 clinical trial of the GI Sleeve for Type 2 diabetes mellitus has completed and results were posted in 2016.
-
CLINICAL_TRIALS withdrawal · 2016-12-26Clinical Trial Update: Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass [NA]
A Duke University-sponsored trial investigating intestinal remodeling and glucose metabolism after Roux-en-Y gastric bypass has been withdra…
-
FDA approval · 2016-12-23FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approves a supplemental application for Tradjenta (linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc., enabling an updated…
-
FDA approval · 2016-12-23FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceutica…